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Improving motor neuron‑like
cell differentiation of hEnSCs
by the combination of epothilone
B loaded PCL microspheres
in optimized 3D collagen hydrogel
Narges Mahmoodi1, Jafar Ai2, Zahra Hassannejad3, Somayeh Ebrahimi‑Barough2,
Elham Hasanzadeh4, Houra Nekounam5, Alexander R. Vaccaro6 & Vafa Rahimi‑Movaghar1*
Spinal cord regeneration is limited due to various obstacles and complex pathophysiological events
after injury. Combination therapy is one approach that recently garnered attention for spinal cord
injury (SCI) recovery. A composite of three-dimensional (3D) collagen hydrogel containing epothilone
B (EpoB)-loaded polycaprolactone (PCL) microspheres (2.5 ng/mg, 10 ng/mg, and 40 ng/mg EpoB/
PCL) were fabricated and optimized to improve motor neuron (MN) differentiation efficacy of human
endometrial stem cells (hEnSCs). The microspheres were characterized using liquid chromatographymass/mass spectrometry (LC-mas/mas) to assess the drug release and scanning electron microscope
(SEM) for morphological assessment. hEnSCs were isolated, then characterized by flow cytometry,
and seeded on the optimized 3D composite. Based on cell morphology and proliferation, crosslinked collagen hydrogels with and without 2.5 ng/mg EpoB loaded PCL microspheres were selected
as the optimized formulations to compare the effect of EpoB release on MN differentiation.
After differentiation, the expression of MN markers was estimated by real-time PCR and
immunofluorescence (IF). The collagen hydrogel containing the EpoB group had the highest HB9 and
ISL-1 expression and the longest neurite elongation. Providing a 3D permissive environment with
EpoB, significantly improves MN-like cell differentiation and maturation of hEnSCs and is a promising
approach to replace lost neurons after SCI.
Spinal cord injury (SCI) is a very common traumatic event and is mainly caused by falls and motor vehicle
accidents (MVAs)1,2. Extensive neuron loss and axon degeneration are common cellular findings at the lesion
site following SCI, leading to severe disability in patients due to limited neuronal regeneration and r ecovery3–5.
Currently, no therapy is available for complete functional recovery after S CI6,7, however, advances in medical
care can increase life expectancy in patients with SCI and reduce their families’ financial burden8,9. As a growing
research area, using various stem cells has been garnered great attention for nerve tissue regeneration through
cell differentiation for lost cell replacement, anti-inflammatory effects, and neurotrophic factor s ecretion4,10.
However, stem cell therapy utility is usually limited given low cell survival and uncontrollable cell differentiation at the site of i njury4. SCI also leads to complex, destructive biological processes that may continue up to
one year after injury11. Thus, to reach the full potential of stem cells, a synergistic effect through combination
therapy is necessary12.
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One of the most promising stem cells for SCI therapy is a group of adult multipotent mesenchymal stem cells
(MSCs), which can be induced to different cell t ypes13–15. Human endometrial stem cells (hEnSCs) as a MSCs
have considered attention for cell therapy and tissue e ngineering16–20. Interestingly, in a recent study, a comparison between hEnSCs and human bone marrow stem cells (hBM-MSCs) showed a better motor neuron (MN)
differentiation potential for h
 EnSCs21. Improvement in differentiating stem cells into specialized neurons is one
solution for replacing damaged or lost cells, thereby leading to potential functional recovery22.
Motor neurons are a type of nerve cells that end at myocytes and transfer nerve impulses to control voluntary
muscle movements. After SCI, there is a substantial loss of motor neurons and interneurons in the spinal cord
tissue23, while endogenous regeneration of neurons and revival of motor function is limited24. A spectrum of
illnesses such as spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS) can also lead to motor
neuron degeneration25. To cure these illnesses, researchers are trying to develop methods to produce MN-like
cells from stem c ells26. MN-derived cells can also be utilized for MN-modelling and drug-screening a ssays27,28.
Microtubules (MTs) are a type of cytoskeletons that, as a structural component, are essential for cellular polarization, neuronal morphology, axonal regeneration, motility, protein secretion, and intracellular m
 ovement29,30.
31,32
MTs disruption and disorganization are characteristics of damaged nerve cells after S CI . Likewise, MTs
disorganization has been noticed as a primary etiology of neurodegenerative diseases such as Alzheimer’s and
Parkinson’s diseases33,34, and, recently, microtubule-stabilizing agents (MSAs) have been considered in the treatment strategy of these d
 isorders35.
Epothilone B (EpoB), also known as patupilone, is a macrolide derived from myxobacteria Sorangium cel‑
lulosum and an MSA that can cross the blood–brain barrier (BBB). A recent study showed that EpoB can induce
axon regeneration and elongation in damaged nerve cells and decrease scar formation after SCI in r odents36–38.
These studies, however, used systemic administration of drugs, and the possible side effects and short half-life
limit us from reaching maximal efficacy. Moreover, various injections require invasive medical intervention.
A biocompatible and biodegradable delivery system can offer sustained release of therapeutic agents and thus
increase their effectiveness without using excessive invasive surgical techniques24. For the delivery of drugs, they
can be encapsulated into biomaterial-based microspheres for sustained release, which provides in situ sustained
release39.
In the field of tissue engineering, utilizing naturally derived hydrogels have gained momentum for localized
drug delivery application for presenting easily mimicking and integrating with native tissues, for similar characteristics to soft tissues, and their excellent recognition by different cell t ypes40–42.
Among various natural-based hydrogels, collagen is the major protein of the extracellular matrix (ECM) in
many mammalian t issues43. Collagen is distinguished being a highly biocompatible cellular growth supporter
and is noncytotoxic44. Though collagen has been extensively used in the clinic and tissue engineering for various
applications45, its high degradation degree, mechanical instability, and thermosensitivity have led researchers
to add other polymers or cross-linkers to achieve more desirable f eatures40,46. Therefore, in this study, we chose
a cross-linking approach to improve hydrogel stability while preserving the utility of collagen hydrogel as an
appropriate three-dimensional (3D) structure for enhancing cell proliferation and differentiation. Many different
kinds of cross-linked hydrogels have been used as 3D scaffolds and drug delivery systems for soft tissue engineering, including corneal, cartilage, skin, tendon, and peripheral and central nervous tissues47–49.
Proanthocyanidin (PA) is a natural polyphenolic oligomeric flavonoid found in flowers, vegetables, fruits,
seeds, nuts, and b
 arks50,51. PA is a promising cross-linker with a variety of biological activities, including antiinflammatory, anti-tumor, antioxidant, anti-bacterial, anti-calcification. PA provides biocompatible crosslinked hydrogels and has non-toxicity properties, unlike common cross-linkers such as formaldehyde and
glutaraldehyde52–55.
Evidence shows that combination strategies achieve greater results than using each component separately by
addressing various aspects of SCI p
 athophysiology12. Accordingly, in this study, we aimed to enhance the differentiation potential of hEnSCs into MN-like cells and axonal elongation using the signaling molecules sonic
hedgehog (SHH) and retinoic acid (RA), and also by providing a hydrogel-based 3D microenvironment capable
of controlling the release of EpoB using PCL microspheres.

Materials and methods

Isolation and culture of human endometrial stem cell (hEnSC). hEnSCs were isolated according

to a previous study56. The collection of discarded endometrium biopsies from patients was achieved via the
informed consent from the patients/legal guardian. All methods were performed in accordance with the relevant
guidelines and regulations of Tehran University of Medical Sciences and approved by the university’s ethical
committee (code: IR.TUMS.REC.1394.1137). Briefly, biopsies of endometrium were washed with phosphatebuffered saline (PBS; Sigma, P4417) containing 2–3% amphotericin B and penicillin/streptomycin, were cut
into small pieces and digested with collagenase type I (1 mg/mL, Sigma-Aldrich) in Dulbecco’s Modified Eagle
Medium/Nutrient Mixture F-12 (DMEM-F12; Invitrogen) for 2 h at 37 °C. The enzyme was then neutralized by
adding a complete medium composed of DMEM-F12 with 10% fetal bovine serum (FBS; Gibco, 10270-106).
Subsequently, the samples were passed through 70 μm and 40 μm filters and were centrifuged at 1200 rpm for
5 min. After the supernatant was removed, the pellet of cells was resuspended in a complete medium containing
10% FBS and 1% penicillin/streptomycin. The cell suspension was transferred to 6-well cell culture plates and
incubated in a humidified chamber at 37 °C with 5% C
 O2. The medium was exchanged every 3 days. Three or
four passages of hEnSCs were used for all of our experiments.

Flow cytometry.

To confirm the identity of the isolated cells, passage three cells were used for flow cytometry BD FACSCalibur (BD Biosciences, USA). The evaluated markers were as follows: endometrial stem cell
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Cell surface marker

Percentage (%)

Antibody

Catalog number

Endometrial stem cell marker

CD146

89.1

PE-conjugated anti-CD146

BD Biosciences, 561013

CD105

98.4

PerCP-conjugated anti-CD105

BioLegend, 323216

Mesenchymal stem cell marker

CD90

98.4

FITC-conjugated anti-CD90

Exbio, 1F-652-100T

CD44

98.5

FITC- conjugated anti-CD44

Immunostep, 44F2-100T

CD45

0.3

FITC-conjugated anti-CD45

BD Biosciences, 560976

Hemopoietic stem cell marker
Endothelial marker

CD34

0.8

PE-conjugated anti-CD34

Exbio, 1P-664-T025

CD31

0.3

PE-conjugated anti-CD31

Immunostep, 31PE-100T

Table 1.  Markers for hEnSCs identification. PE phycoerythrin, PerCP peridinin chlorophyll protein, FITC
fluorescein isothiocyanate.

marker (CD146), mesenchymal stem cell markers (CD44, CD90, and CD105), hematopoietic stem cell markers
(CD34 and CD45), and endothelial stem cell markers (CD31).
The cells were washed three times with Hank’s Balanced Salt Solution (HBSS) and 2% bovine serum albumin
(BSA; Sigma, A7030) and then were incubated with a specific antibody (Table 1) at concentrations recommended
by the respective manufacturers (for 1 h). Data were evaluated by FlowJo Version 7 software.

Green fluorescent protein (GFP) labeled hEnSCs. Based on previous studies, lentivirus (second-generation) was used for GFP gene transduction of hEnSCs and HEK293-T cells57. We also labeled HEK293-T as the
standard cell line with high efficiency for GFP labeling. The pCDHCop GFP-Pru plasmid was used for labeling,
which contained EF-1α promotor to upregulate the expression of GFP transgene. For transient transfection of
HEK293-T, the vector associated with psPAX2 as a packaging plasmid and pMD2.G as an envelope plasmid
were used via the calcium phosphate precipitation method. Then, the viral particles were harvested from the
supernatant for 3 days, then stored at − 80 °C. HEK293-T (30% confluency) and hEnSCs (50% confluency)
were then transduced by adding 5 μg/mL polybrene and lentiviral particles. Labeled cells were selected using
10 μg/mL puromycin, which was added to DMEM-F12. GFP expression was observed in hEnSCs via fluorescent
microscopy after 3 days.
Microsphere fabrication and sterilization. The oil in water (o/w) single emulsion method was used to

synthesize the EpoB-loaded PCL microspheres. First, 250 mg of polycaprolactone (PCL; Sigma, 363170) was dissolved in 2 mL of dichloromethane (DCM; Sigma, 32222) using a magnet stirrer (Heidolph, Hei-Tec) for 25 min
at 35 °C. Three groups of EpoB-loaded PCL microspheres were fabricated by adding 0.625 µg, 2.5 µg, and 10 µg
of EpoB (Abcam, 152044-54-7) to the PCL solution for an EpoB loading of 2.5 ng/mg, 10 ng/mg, and 40 ng/mg
(EpoB/PCL), respectively. Unloaded microspheres were synthesized through the elimination of EpoB from the
formulation. 2 mL of pure ethanol (Merck, 111727) was added to the solution while stirring, and 2 mL of 2%
(w/v) polyvinyl alcohol (PVA) (Sigma, 363170) solution was slowly added drop by drop without disrupting the
boundary layer. Then, the solution was mixed and emulsified for 12 s using a vortexer (Heidolph) and instantly
added to a 100 mL beaker containing 50 mL of 0.3% (w/v) PVA solution at 35 °C. To evaporate the organic
solvent, the solution was stirred with a 3 cm × 0.5 cm round magnetic stirring bar at 500 revolutions per minute
(rpm) for 4 h in a 100 mL beaker. Since EpoB is light sensitive, the entire fabrication process was performed in
a dark room. It is worth noting, due to the importance of mentioning parameters such as magnetic bar’s length,
diameter, and the size of cylindrical container for having a reproducible particle synthesis method, these specifications were mentioned above58.
The synthesized microspheres were collected through centrifugation at 4000 rpm (Eppendorf, 5810R) for
10 min and were washed four times with distilled water and centrifugation at 4000 rpm for 5 min each time to
remove residual PVA. Then, the microspheres were frozen at − 80 °C, lyophilized for 24–48 h, and were stored
at − 20 °C. For cell culture experiments, microspheres were sterilized by air-plasma for 30 s on low power (Harrick, PDC-32G).

Microsphere characterization. Scanning electron microscopy (SEM). To evaluate the size and morphol-

ogy of microspheres, a ZEISS DSM 960A Oberkochen (Germany) scanning electron microscope (SEM) was
used. Microspheres were sputter-coated with gold (20 kV for 4 min), and after imaging, their diameters were
quantified using ImageJ software. The distribution of microsphere diameters was plotted as a histogram. Each
sample was displayed from smallest to largest diameter.
Determination of encapsulation efficiency (EE). After synthesizing 2.5 ng/mg, 10 ng/mg, and 40 ng/mg (w/w,
EpoB/PCL) EpoB microspheres, the suspension of each group was centrifuged at 4000 rpm for 10 min at room
temperature to separate the microparticles and supernatant. The amount of EpoB in the supernatant was evaluated as the extent of unencapsulated EpoB using liquid chromatography-mass/mass spectrometry (LC-Mas/
Mas; HPLC Alliance 269S Waters, Quattro Micro API micromass micromass) with a C18 column (4.8 × 150 mm,
5 µm, Agilent Zorbax XDB). The standard solutions of EpoB and each microsphere sample were loaded to
LC–MS/MS and first eluted with methanol: water (40:60) for 5 min at the speed of 0.5 mL/min and then

Scientific Reports |

(2021) 11:21722 |

https://doi.org/10.1038/s41598-021-01071-2

3
Vol.:(0123456789)

www.nature.com/scientificreports/
methanol:water (95:5). The retention time of EpoB was 9 min. The samples were quantified based on the standard curve of EpoB (all samples were run in triplicate).
The encapsulation efficiency (EE) of EpoB in the PCL microparticle was determined as the following formula:

EE% =

Total Epo B added (ng) − Unbound Epo B (ng)
× 100%
Total EpoB used (ng)

EpoB release measurement. 10 mg of 2.5 ng/mg, 10 ng/mg, and 40 ng/mg (w/w, EpoB/PCL) EpoB-loaded
microspheres were suspended in 1.5 mL of PBS in a Costar® Spin-X® centrifuge tube filter (0.22 µm pore CA
membrane; Corning, 8160). The microspheres were placed in the above chamber containing the filter, filled
with 0.5 mL PBS, and the tube filled with 1 mL PBS. These tubes were used to prevent microspheres from being
mistakenly collected at the time of sampling. The Costar® Spin-X® centrifuge tubes were then placed on a shaker
(Lab Tech, LSI-3016R) at 100 rpm and incubated at 37 °C. For the in vitro study, to simulate the conditions of
exchanging the culture medium, in the release test, the PBS was exchanged every 2 days. Three samples were
considered for each time point (7-time points: 1 and 18 h and 1, 3, 6, 14, and 21 days). The PBS of each sample
was collected entirely at each time point. First, the PBS of the tubes was collected (not the above chamber that
contained the filter), then each chamber was centrifuged with its tube at 4000 rpm for 5 min until the PBS in the
chamber inter the tube and could be collected. The PBS was then stored at − 80 °C and protected from light until
all the samples were collected for further analysis.
The amount of EpoB was determined by using LC-Mas/Mas. In addition, to better identify the drug amount,
the samples were first concentrated six times. For this purpose, each 1.5 mL samples were freeze-dried for 24–48 h
and then dissolved in 200 µL deionized water and 50 µL methanol. For cell culture application, the candidate
microspheres were then sterilized by air plasma (Harrick, PDC-32G) on low power for 30 s.

Determining the effect of microspheres on cell viability and proliferation. According to experimental release results, the microsphere containing 2.5 ng/mg (EpoB/PCL) was selected as the candidate microsphere for this study, referred to as Mic-2.5-EpoB in this text. To determine the biocompatible concentration of
microparticles for hEnSCs culture, first, different concentrations of unloaded PCL microspheres (5, 10, 15, and
40 mg/mL) were used by indirect MTT assay for 24, 48, and 72 h. After evaluating their results, a second indirect
MTT assay was performed for Mic-2.5-EpoB for 24, 48, and 72 h to assess the effect of the loaded microsphere
on viability and proliferation of hEnScs. For both MTT assays, 2 × 105 hEnSCs were seeded in each 24-well cell
culture plate containing 500 µL of complete medium and incubated at 37 °C, 5% CO2 for 24 h. Then, the cell
culture was replaced with extract solutions of the microspheres and incubated at 37 °C, 5% C
 O2 for 24, 48, and
72 h. The microsphere extract solutions of the (5, 10, 15, and 40 mg/mL unloaded PCL microspheres and Mic2.5-EpoB) in complete medium (DMEM-F12 + 10% FBS) were collected every 24 h (each group was performed
in triplicate). For each time point, the medium was removed and replaced with 5 mg/mL tetrazolium (Sigma) in
PBS (MTT solution) and incubated for 3 h at 37 °C, 5% C
 O2. The optical density (OD) of formazan dye dissolved
in dimethyl sulfoxide solution (DMSO) was obtained using an ELISA microplate reader (Gen5, Power Wave
XS2, BioTek, USA) at 590 nm. The following formula calculated the cell viability percent of hEnSCs:
%Cell Viability =

OD treated well
× 100
OD control well

The MTT test was also used to determine the permissible particle limit in the cell culture for hEnSCs.

Fabrication of collagen hydrogels. Collagen type I was extracted from rat tails following a previously
developed method59. Collagen was sterilized through dialysis with 1% chloroform (Merck) using dialysis bags
with a molecular cut of 6–8 kDa (SpectraPor, 132660) for 1 h at 4 °C.
Collagen hydrogels were fabricated using a ratio of 8:1:1 of sterile collagen solution:10 × DMEM/F12:HSS
buffer. The HSS buffer was prepared by dissolving 4.77 g HEPES and 2.2 g sodium bicarbonate in 100 mL of
0.5 M sodium hydroxide. For gelation, 500 µL of the prepared mixture was poured into 24-well cell culture plates
and incubated at 37 °C for 1 h. Two final concentrations of collagen were used to fabricate the hydrogels: 2 mg/
mL and 4 mg/mL.
To improve stability of the hydrogel, collagen hydrogels were also cross-linked using different concentrations
of proanthocyanidin (Grape Seed, Proanthocyanidins, S hari®, Iran) in PBS, including 0.25% PA, 0.5% PA, and
also 0.5% PA with 0.05 M Ca(OH)2 (PA-Ca(OH)2). In the last formulation, we used Ca(OH)2 based on evidence
indicating that Ca(OH)2 facilitates the penetration of PA and collagen cross-linking52. After one-hour incubation
of collagen solutions (2 mg/mL and 4 mg/mL) at 37 °C, 100 µL of PA solution was added, and the cell culture
plates were further incubated for 48 h at room temperature in a sterile condition. Then, the hydrogels were
washed with PBS three times to remove the excess crosslinkers. The specifications of hydrogel preparation are
summarized by code in Table 2.
Fabrication of collagen hydrogel containing EpoB‑loaded microspheres. To mix EpoB micro-

spheres with collagen hydrogel for 3D culture application, candidate microspheres were coated with a dilute
sterilized collagen solution (0.5 mg/mL) overnight at 4 °C. Before coating, the collagen solution was neutralized
using a 1 N solution of filter-sterilized NaOH in water (syringe-filter 0.22-µm membrane), bringing the pH to
around 7.4.
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Hydrogel code

Desorption

Collagen

Collagen hydrogel

2-Col/PA-CH

Cross-linked 2 mg/collagen hydrogel with 0.5% proanthocyanidin and calcium hydroxide

4-Col/PA-CH

Cross-linked 4 mg/collagen hydrogel with 0.5% proanthocyanidin and calcium hydroxide

2-Col/PA-CH/Mic EpoB

Cross-linked 2 mg/mL collagen hydrogel with 0.5% proanthocyanidin (PA) and calcium hydroxide and 2.5 ng/
mL Epo B microspheres

4-Col/PA-CH/Mic EpoB

Cross-linked 4 mg/mLcollagen hydrogel with 0.5% proanthocyanidin (PA) and calcium hydroxide and 2.5 ng/
mL Epo B microspheres

Table 2.  The code used for different hydrogels prepared through thermal and chemical cross-linking.

Cell seeding within the collagen hydrogels. In each 24-well culture plate, 50 µL of 1 × 105 hEnSCs in
complete medium (DMEM-F12 and 10% FBS) was slowly added to collagen hydrogels and incubated for 30 min
at 37 °C for cells attachment. Then, 150 µL complete medium was added to each well.
Cell morphology, attachment, and proliferation on the collagen hydrogels. Fluorescent microscopy. To study
cell adhesion, morphology, and proliferation in collagen hydrogels, two types of GFP-labeled cells (HEK293-T
and hEnSCs) were used. In each 24-well cell culture plate, 1 × 105 cells were seeded and incubated at 37 °C with
5% CO2. To observe the cells, an Olympus (BX51, Japan) immunofluorescence microscope was used.
Scanning electron microscope. An SEM (AIS2300C SEI, Korea) at 20 kV was used for investigating cell attachment of hEnSCs on collagen, 2-Col/PA-CH, and 2-Col/PA-CH/Mic EpoB hydrogel scaffolds, after 48 h of cell
seeding. The SEM was also performed for observing the surface morphology of collagen, 2-Col/PA, 2-Col/
PA-CH, and 2-Col/PA-CH/Mic EpoB hydrogel scaffolds. The medium of each 24-well was discarded, and each
specimen was washed with PBS and fixed with Karnovsky’s fixative solution (consisting of 2% paraformaldehyde
and 2.5% glutaraldehyde) at room temperature for 1 h. Subsequently, the prepared samples were washed twice
with PBS and then dehydrated with a graded ethanol series of 30, 50, 70, 90, 95, and 100%. Afterward, to examine the specimens via SEM, the samples for cell attachment study were first dried on an aluminum foil at room
temperature, and the samples for surface morphology study were freeze-dried for 48 h, then each sample was
under vacuum and finally coated with gold sputtering.

Hydrogel biodegradation degree. We assessed the degradation degree of collagen, 2-Col/PA-CH, and
2-Col/PA-CH/Mic EpoB hydrogels based on their weight loss in DMEM-F12 medium at 37 °C. The DMEM-F12
medium was exchanged every 3 days. Hydrogel weight alterations were evaluated over 14 days (all time points
were run in triplicate). The degradation degree was calculated using the following equation:
Degradation degree =

(W0 − Wt )
100%
W0

where, W0 and Wt indicate the weight of hydrogels before and after immersing in medium, respectively.

Swelling degree. The swelling degree of the hydrogel scaffolds, including collagen, 2-Col/PA-CH, and
2-Col/PA-CH/Mic EpoB were measured for 96 h. The hydrogels were allowed to swell in DMEM-F12 at 37 °C.
Each time point was performed in triplicate.
The weight of the wet samples was measured, and the swelling degree was obtained via the following formula:
Swelling degree =

(Wt − W0 )
× 100
W0

where, W0 and Wt are the weight of the primitive hydrogel and the weight of the swollen hydrogel, respectively.

ATR‑FTIR spectroscopy. Proanthocyanidin (PA; GrapeSeed, Shari®, Iran) blended tablets were first dissolved in water. Then the precipitated additives of the tablet were removed and filtered through a 0.22 μm membrane. The samples (PA, Collagen, 2-Col/PA, and 2-Col/PA-CH) were freeze-dried for 48 h and then analyzed
using an ATR accessory (Nicolet Avatar, Thermo Fisher Scientific, Waltham, MA, USA).
Differentiation of hEnSCs into motor neuron‑like cells within 3D collagen hydrogels contain‑
ing EpoB‑loaded microspheres. Differentiation of hEnSCs was conducted in a three-step approach26

using 24-well cell culture plates with different experimental groups, including collagen hydrogel without Mic
EpoB (2-Col/PA-CH), collagen hydrogel with Mic EpoB (2-Col/PA-CH/Mic EpoB), tissue culture plate (TCP;
hEnSCs differentiation without Mic EpoB and collagen hydrogel), and control (undifferentiated hEnSCs). 2 × 105
hEnSCs in complete medium (DMEM/F12 and 10% FBS) at passage three were seeded on different substrates
and incubated at 37 °C and 5% C
 O2. After 24 h, in step one, the complete medium was replaced with a preinduction (PrI) medium, and cells were incubated for 24 h. In step two, the PrI medium was exchanged with the
induction medium, and cells were incubated for 7 days (the medium was exchanged after 3 days). In step three,
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Step

1

2

3

Differentiation medium

Pre-induction (PrI) medium

Induction medium (exchanged after 3 days)

Maturation (survival) medium (exchanged
after 3 days)

Ingredients

Catalog number

DMEM/F12 (1:1)

Invitrogen, 32500-035

20% FBS

Gibco, 10270-106

2% B-27 supplement

Gibco, 17504-044

100 μM 2-Mercaptoethanol

Sigma, M3148

250 μM isobutylmethylxanthine (IBME)

Sigma, I5879

10 ng/mL fibroblast growth factor 2 (FGF2)

Sigma, SRP4037

DMEM/F12 (1:1)

Invitrogen, 32500-035

0.2% B-27 supplement

Gibco 17504-044

100 ng/mL sonic hedgehog (SHH)

Sigma, SRP3156

0.01 μM retinoic acid (RA)

Sigma, R2625

DMEM/F12 (1:1)

Invitrogen, 32500-035

0.2% B-27 supplement

Gibco 17504-044

100 ng/mL glial cell-derived neurotrophic
factor (GDNF)

Sigma, G1777

Duration

1 days

7 days

7 days

200 ng/mL brain-derived neurotrophic factor
Sigma, SRP3014
(BDNF)

Table 3.  The procedure and reagents used for differentiation of hEnSCs into motor neuron-like cells on 3D
collagen hydrogels with or without EpoB-loaded PCL microspheres or cell culture plates.

Antibody/stain

Catalog number

Dilution

Anti-beta-III-tubulin antibody (Tuj-1) (rabbit monoclonal)

Abcam, ab68193

1:200

Anti-Islet-1 (mouse monoclonal)

Abcam, ab86472

1:200

Anti-choline acetyltransferase (CHAT; mouse monoclonal)

Santa Cruz, sc-55557

1:200

Anti-nestin (NES; mouse monoclonal)

PadzaCo, MN105

1:200

Anti-Homeobox 9 (HB9; mouse monoclonal)

Santa Cruz, sc-515769

1:50

Primary antibody

Secondary antibody
Goat anti-rabbit IgG (H + L) cross-adsorbed secondary antibody, Alexa Fluor 488

Gibco, A-11008

1:500

Goat anti-mouse IgG (H + L) highly cross-adsorbed secondary antibody Alexa Fluor 594

Gibco, A-11032

1:700

Sigma-Aldrich, D8417

1:1000

Nuclear stain
4′,6-Diamidino-2-phenylindole (DAPI)

Table 4.  Primary and secondary antibodies were used for immunofluorescence staining.

the induction medium was replaced with a maturation medium, and incubation was continued for an additional
7 days (the medium was exchanged after 3 days). All procedures and reagents are summarized in Table 3.

Immunofluorescence (IF) staining. All samples were fixed using 4% paraformaldehyde in PBS for
30 min at room temperature and then permeabilized using 0.2% Triton X-100/PBS. The cells were blocked
using 5% BSA/PBS for 45 min at room temperature and incubated overnight with primary antibodies at 4 °C
(Table 4). Then, each sample was washed three times with PBS/Tween 20 (0.1%, Sigma). Secondary antibodies
were added, and samples were kept in the dark for one hour at room temperature. Cells were again washed with
PBS/Tween 20 (0.1%) three times. Cell nuclei were counterstained with 4′,6-diamidino-2-phenylindole (DAPI;
Sigma-Aldrich, D8417). For the negative control group, only secondary antibodies were used.
RNA extraction and cDNA synthesis. Total RNA extraction was conducted using RNX Plus™ low copy
RNA isolation (CinnaGen, Iran, EX6101), chloroform, isopropyl alcohol, and 75% ethanol. The purity and quantity of each extracted RNA were assessed using a Nanodrop spectrophotometer (Thermo Scientific, USA). cDNA
synthesizing was conducted using PrimeScript™ RT Reagent Kit (Takara, RR037A) following the manufacturer’s
instruction (Thermocycler schedule: 15 min at 37 °C, 5 s at 85 °C).
Real‑time RT‑PCR for gene expression analysis. All primers were obtained from Qiagen (Germany)

(Table 5). RealQ RNA quantitative measurement was evaluated using Plus 2 × Master Mix Green (AMPLIQON,
5000850-1250) on a real-time thermocycler (Rotor-Ge4ne Q, Corbett Life Science, USA) (Table 6). PCR product
specificity was evaluated by confirming a single peak in the melting curve analysis. All experimental samples
were performed three times in duplicate. RPL13A was selected as a housekeeping gene, and each gene fold-
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Gene

Assay name

Catalog number (Qiagen)

Genebank accession number Amplicon length (bp)

NES [Human]

Hs_NES_2_SG QuantiTect
Primer Assay

QT01015301

NM_006617

75

ISL1 [Human]

Hs_ISL1_1_SG QuantiTect
Primer Assay

QT00000294

NM_002202

83

NEFH [Human]

Hs_NEFH_1_SG QuantiTect
Primer Assay

QT00209181

NM_021076

97

MNX1 [Human]

Hs_MNX1_vb.1_SG QuantiTect Primer Assay

QT02407384

NM_005515

130

RPL13A [Human]

Hs_RPL13A_1_SG QuantiTect Primer Assay

QT00089915

NM_012423

161

Table 5.  Primers used for real-time RT-PCR.

Reaction detail

Real-time PCR schedule

Component

Volume

Step

Temperature

Time

SYBR Green I Master Mix

5 µL

Initial denaturation

95 °C

15 min

Diluted cDNA (1:10)

1 μL

Denaturation at

94 °C

15 s

Related primer

1 μL

Annealing temperature

60 °C

30 s

3 µL

Extension

72 °C

30 s

dH2O

Total 10 µL

Table 6.  Reaction conditions of real-time PCR.

change was calculated relative to RPL13A based on relative quantitation evaluation via the ΔΔCT method, using
the 2−ΔΔCT relative expression equation. A summary of the different steps of the study is shown in Fig. 1.

Analysis and quantification of neurite extension. Analysis of neurite extension was investigated

using an inverted phase-contrast microscope (Olympus, Japan) attached to a digital camera (DP50). For each
experimental group, five random representative areas were selected for neurite length measurement using
ImageJ software.

Statistical data analysis. Data were analyzed using SPSS 21 software. One-way ANOVA and Dunnett’s

two-tailed t-test (DUNNETT) were employed to evaluate the statistical significance of differences between the
control and all experimental groups.

Ethics declarations. Ethical approval for collecting biopsy disposal of patients human endometrial was
obtained from the Ethics Committee of Tehran University of Medical Sciences (code: IR.TUMS.REC.1394.1137).
An informed consent was obtained from patients/legal guardians according to Tehran University of Medical Sciences guidelines. All methods were performed in accordance with the relevant guidelines and regulations.

Results

Characterization of hEnSCs derived from endometrium. The hEnSCs were positive for mesenchy-

mal stem cell markers CD44 (98.5%), CD90 (98.4%) and CD105 (98.4%), endometrial stem cell marker CD146
(89.1%). hEnSCs were also negative for hematopoietic CD45, CD34, and endothelial CD31 markers (Fig. 2a).

Cell GFP transduction. Two types of cells, HEK293-T, and hEnSCs were labeled. As shown in Fig. 2b, cells
were effectively transduced by GFP-encoding lentiviral particles. The GFP-positive cells were observed by fluorescent phase-contrast microscopy and used to assess cell adhesion and proliferation within hydrogels.

EpoB‑loaded PCL microsphere characterization. Scanning electron microscope. The morphology of
the fabricated microspheres was assessed using SEM. SEM images indicated a round shape with some clustering
and smooth surface. The diameters of 2.5, 10, and 40 ng/mg EpoB/PCL microspheres were 3.143 ± 1.485 µm,
4.747 ± 3.434 µm, and 2.931 ± 1.543 µm, respectively. Compared to the EpoB/PCL microspheres, the unloaded
microspheres were larger, with a diameter of 6.570 ± 4.833 (P < 0.001) (Fig. 3a–h).
Encapsulation efficiency. The encapsulation efficiencies (EE) for different loading concentrations of EpoB are
shown in Table 7. A greater EE was obtained in PCL microspheres with higher EpoB loading levels, indicating
that the initial concentration of EpoB can potentially affect EE of EpoB in PCL microspheres using the single
emulsion fabrication method.
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Figure 1.  A schematic presentation of different steps of the study, including; EpoB microspheres synthesis
using single emulsion, collagen extraction from rat tail, synthesis of collagen hydrogel and its crosslinking using
proanthocyanidin from grape seed and calcium hydroxide (PA-CH), cell isolation, and culturing from human
endometrium, and a three-step MN-differentiation (during 15 days).
EpoB release. As shown in Fig. 3i, there was a burst release in the initial first 24 h for all groups, followed by a
slower gradual release for 2.5 and 10 ng/mg EpoB/PCL microspheres, which reached a plateau. However, compared to 2.5 and 10 ng/mg EpoB/PCL microspheres, the 40 ng/mg EpoB/PCL microspheres maintained a higher
release rate over 21 days, indicating that the release rate is influenced by the amount of EpoB encapsulated in
the microspheres. According to the EpoB release results, 2.5 ng/mg was selected due to its appropriate sustained
release dosage for neuronal differentiation.

Proliferation and viability assessment of microspheres. To find the permissible limit, the effect of
four different concentrations of unloaded PCL microspheres (unloaded Mic: 5, 10, 15, and 40 mg/mL) were
assessed for viability and proliferation of hEnSCs during 24, 48, and 72 h using the MTT assay. The effect of the
candidate microsphere 2.5 ng/mg (Mic EpoB) on hEnSCs was also evaluated by indirect MTT assay for 24, 48,
and 72 h (Fig. 3j). The results indicated no cytotoxicity in all four PCL microsphere concentrations. For Mic
EpoB, cell proliferation increased after 24 h. The Mic EpoB cell viability at 48 and 72 h after treatment was 94.1%
(P < 0.01) and 76.5% (P < 0.001), respectively.
Cell morphology, attachment, and proliferation. Fluorescent microscopy. Collagen hydrogels

improved adhesion and proliferation of HEK293-T (as a typical well-transected GFP cell) and hEnSCs-GFP.
As shown in Figs. 4 and 5, the effect of hydrogel fabricated using 2 mg/mL collagen was more prominent on
cell proliferation compared with hydrogel fabrication using 4 mg/mL collagen. Furthermore, among different

Scientific Reports |
Vol:.(1234567890)

(2021) 11:21722 |

https://doi.org/10.1038/s41598-021-01071-2

8

www.nature.com/scientificreports/

Figure 2.  Characterization of cell markers for hEnSCs and verification of GFP-labeling. (a) The results of flow
cytometric assessment of hEnSCs at passage three, isolated from the endometrial biopsy. Dark red lines display
isotype control (negative control). hEnSCs were positive for mesenchymal stem cell markers CD44 (98.5%),
CD90 (98.4%), and CD105 (98.4%), endometrial stem cell marker CD146 (89.1%), shown as a right shift of the
fluorescent intensity peak. hEnSCs were also negative for hematopoietic CD45, CD34, and endothelial CD31
markers (no shift of the fluorescent peak was observed). (b) HEK293-T and hEnSCs transduction with GFPexpressing lentiviral vectors. To confirm GFP expression, the labeled HEK293-T and hEnSCs were monitored
with a fluorescent microscopy.
groups, the 0.5% PA-CH hydrogel had the greatest cell proliferation compared to other PA-crosslinked collagen
hydrogels in both 2 mg/mL and 4 mg/mL collagen concentrations (i.e., 2-Col/PA-CH and 4-Col/PA-CH). Since
the 2-Col/PA-CH hydrogel had a more prominent effect on cell proliferation compared to 4-Col/PA-CH, this
formulation was selected as the optimized hydrogel for further experiments.
Scanning electron microscope (SEM). SEM images of hEnSCs cultured on collagen, 2-Col/PA-CH, and 2-Col/
PA-CH/Mic EpoB hydrogels indicated cell-scaffold interactions and cell attachment on hydrogel scaffolds 48 h
after cell seeding (Fig. 6a–c,e). The interconnected porosity and surface morphology of the hydrogel scaffolds
was revealed by SEM. In the 2-Col/PA-CH/Mic EpoB hydrogel, the EpoB microspheres were visible and detected
(Fig. 6d,e). The 2-Col/PA and 2-Col/PA-CH hydrogels showed more fibrous and regular structure compared to
collagen (Fig. 6f–h), and the 2-Col/PA-CH hydrogel indicated a smooth surface morphology.

Hydrogel biodegradation. The degradation of different hydrogel formulations, including collagen, 2-Col/

PA-CH, and 2-Col/PA-CH/Mic EpoB, during 14 days of incubation in DMEM-F12 medium at 37 °C was evaluated (Fig. 7a). The degradation degree of collagen hydrogel was higher than the other two groups (i.e., 2-Col/
PA-CH, and 2-Col/PA-CH/Mic EpoB). Adding of collagen-coated Mic EpoB and PA-CH as a cross-linker
increased the stability of the collagen hydrogel. Furthermore, 2-Col/PA-CH/Mic EpoB showed slower degradation and higher stability compared with 2-Col/PA-CH.

Hydrogel swelling. The swelling degree of collagen, 2-Col/PA-CH, and 2-Col/PA-CH/Mic Epo B hydrogels
in DMEM-F12 was calculated until 96 h (Fig. 7b). The swelling degrees were as follow:

2-Col/PA-CH/Mic Epo > collagen > 2-Col/PA-CH.
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Figure 3.  Characterization of microspheres. Scanning electron microscopy (SEM) and characterization of
unloaded, 2.5, 10, and 40 ng/mg EpoB/PCL microspheres. (a–d) SEM shows smooth morphology and some
microsphere clustering. (e–h) Particle size distribution histogram indicating expected particle size diameters
(Sample size n = 100). (i) The cumulative release profile of 2.5, 10, and 40 ng/mg EpoB/PCL microspheres over
21 days (7-time points). Sample size n = 3. (j) The effect of 2.5 ng/mg EpoB Mic and different concentrations
of PCL microspheres (unloaded Mic) on cell viability of hEnScs. Data are displayed as the percentage of cell
viability in three independent tests, with each test having three individual samples. Cell viability graphs were
compiled using SPSS 21 (clustered bar, summaries for groups of cases). (Error bars: ± 1 SD). P values were
assessed with SPSS 21, using one-way ANOVA and DUNNETT test. The effect of all samples was compared to 0
(control). *P < 0.05, **P < 0.01, ***P < 0.001.

EpoB concentration added

Encapsulation efficiency ± SD (%)

2.5 ng/mg EpoB/PCL

83 ± 1

10 ng/mg EpoB/PCL

88.9 ± 0.5

40 ng/mg EpoB/PCL

93.9 ± 0.3

Table 7.  Encapsulation efficiencies for different drug loading. Sample size n = 3, P < 0.001.
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Figure 4.  HEK293-T-GFP morphology, adhesion, and proliferation within collagen hydrogels. The HEK293T-GFP adhered to (a) 2 mg/mL and (b) 4 mg/mL collagen hydrogel concentrations and all cross-linked collagen
hydrogels (using 0.25% PA, 0.5% PA and 0.5% PA-CH). Over time, more GFP-positive cells were observed,
indicating that the proliferated cells were GFP positive, as well. Cell proliferation was more prominent in
hydrogels fabricated using 2 mg/mL collagen.
The results showed that adding PA-CH as cross-linker causes a decrease in the swelling degree of collagen.
However, the addition of coated collagen microspheres to collagen gel increased the swelling degree of the
hydrogel. The consistency in cross-linked collagen hydrogels is presented in Fig. 7c.

ATR‑FTIR spectroscopy.

The ATR-FTIR spectra of PA, collagen, 2-Col/PA, 2-Col/PA-CH are presented
in Fig. 7d. The main peaks including amide A (3280–3290 cm−1), amide B (3075–3085 cm−1), amide I (1635–
1656 cm−1), amide II (1549–1566 cm−1), amide III (1174–1177 cm−1), aliphatic C–H bond (2925–2942 cm−1),
CH2 bending (1397–1401 cm−1) were detected and pointed out by arrows and dash lines. Additionally, to
enhances the separation of overlapping peaks, second-derivative spectrum in the amide B region was achieved
via irAnalyze software, showing secondary structure conformational changes in the two cross-linked hydrogels
scaffold (2-Col/PA and 2-Col/PA-CH) compared to the collagen (uncross-linked) hydrogel scaffold (Fig. 7e).

The effect of 3D collagen hydrogel and EpoB release on differentiation of hEnSCs into motor
neuron‑like cells. Immunofluorescence staining. After 15 days of MN-induction, the morphology of hEn-

SCs changed from a fibroblast-like shape to a bipolar and round cell body shape with neurites. The neuron-like
morphology was observed using an inverted phase-contrast microscope (Olympus, Japan). IF staining results
showed up-regulation of the MN markers ISL-1, CHAT, and HB9 in all three experimental groups, but no expression in the control group (Fig. 8a).
Differentiation rate was investigated by counting each positive cell marker (beta-tubulin III, ISL-1, CHAT,
NES, HB9) as a percentage of the total number of DAPI-stained cells. The level of positive MN markers expression in cells seeded on 2-Col/PA-CH/Mic EpoB group was significantly higher (P < 0.001) than the other two
groups (i.e., TCP, and 2-Col/PA-CH), except for NES. The positive marker expression of different evaluated
markers in TCP, 2-Col/PA-CH, and 2-Col/PA-CH/Mic EpoB is shown below, respectively. Quantitative results
are also shown in Fig. 8b.

• beta-tubulin III (89%, 92%, 98%,)
• ISL-1 (83%, 88%, 98%)
• CHAT (80%, 85%, 97%)
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Figure 5.  Adhesion and proliferation of hESCs-GFP within collagen hydrogels before and after cross-linking
using different concentrations of PA (0.25% PA, 0.5% PA, and 0.5% PA-CH). (a) Collagen hydrogels were
fabricated using 2 mg/mL collagen with or without Mic EpoB at day 1 and day 6, (b) and a comparison between
hydrogels was performed using different collagen concentrations (i.e., 2 mg/mL and 4 mg/mL) with or without
Mic EpoB at day 6 of culture.
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Figure 6.  Cell attachment and surface morphology of different collagen hydrogel groups. Scanning electron
micrographs of hEnSCs attachment on (a) collagen, (b) 2-Col/PA-CH, and (c) 2-Col/PA-CH/Mic EpoB
hydrogels 48 h after cell seeding. Micrographs show hydrogel with cells at × 1000 and × 3000 magnifications
(pseudo-colored). Scanning electron micrographs of different collagen hydrogel groups (d–h) indicates their
surface morphology and interconnected porosity: 2-Col/PA-CH/Mic EpoB (d,e), collagen (f), 2-Col/PA (g), and
2-Col/PA-CH (h). EpoB microspheres were detected in the 2-Col/PA-CH/Mic EpoB hydrogel (d,e). Moreover,
the cell attachment (highlighted in yellow) and EpoB microspheres (pointed with red arrows) are displayed in
2-Col/PA-CH/Mic EpoB hydrogel in Figure e.
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Figure 7.  Degradation and swelling degree, and ATR-FTIR spectra of different collagen hydrogel groups. (a)
Degradation and (b) swelling degree of collagen, 2-Col/PA-CH (Cross-linked 2 mg/collagen hydrogel with
0.5% proanthocyanidin and calcium hydroxide), and 2-Col/PA-CH/Mic EpoB (Cross-linked 2 mg/mL collagen
hydrogel with 0.5% proanthocyanidin and calcium hydroxide and 2.5 ng/mL Epo B microspheres) hydrogels
in DEME-F12 at 37 °C (The time duration: 14 days for degradation test and 4 days for swelling test). *P < 0.05,
**P < 0.01, ***P < 0.001. (c) The consistency in cross-linked collagen hydrogels. (d) The ATR-FTIR spectra of
PA, collagen, 2-Col/PA, 2-Col/PA-CH and, (e) their second-derivative spectra in the amide B region. The main
peaks are shown by red arrows and gray dash lines. The second-derivative spectra in the amide B region indicate
secondary structure conformational changes in the two cross-linked hydrogels scaffold (2-Col/PA and 2-Col/
PA-CH) compared to the collagen (uncross-linked) hydrogel scaffold.

• NES (100%, 100%, 100%)
• HB9 (78%, 84%, 96%)
Molecular analysis using real‑time‑PCR. After 15 days of cell induction, real-time RT-PCR was performed to
compare the fold-change of RNA expressions of HB9, ISL-1, NES, and NEFH in three experimental groups,
including TCP, 2-Col/PA-CH, 2-Col/PA-CH/Mic EpoB and control (undifferentiated hEnSCs) (Fig. 8c). The
real-time-RT-PCR results indicated that the level of HB9, ISL-1, NES, and NEFH was significantly up-regulated
in all three induced hEnSCs groups (P < 0.001, P < 0.01). Between the three experimental groups, the 2-Col/
PA-CH/Mic EpoB hydrogel had the highest expression level of HB9 and ISL-1 as MN markers (12.4- and 12-fold
change, respectively). The expression of HB9 in the 2-Col/PA-CH/Mic EpoB hydrogel was 4.43- and 4.13-times
higher than the TCP and 2-Col/PA-CH hydrogel, respectively (2.8- and 3-fold change, respectively). The expression of ISL-1 in the 2-Col/PA-CH/Mic EpoB hydrogel was 2.4- and 1.71-times higher than the TCP and 2-Col/
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Figure 8.  The expression of MN-like cells differentiated from hEnSCs in different groups. (a)
Immunofluorescence images of MN-like differentiated hEnSCs in different groups of TCP, collagen hydrogel
without Mic EpoB (2-Col/PA-CH/M), collagen hydrogel with Mic EpoB (2-Col/PA-CH/Mic EpoB), and
control (undifferentiated hEnSCs) for beta-III-tubulin, NES, ISL-1, CHAT, and HB9 after 15 days (× 20, Scale
bar 100 μm). (b) Expression (ratio of positive cells, %) of MN markers calculated from three wells (five fields
per well). (c) Relative gene expression in three differentiated groups, including TCP, Col without Mic EpoB,
Col with Mic EpoB, and control (undifferentiated hEnSCs) after 15 days for NEFH, ISL-1, NES, and HB9.
Graphs were generated with SPSS 21 (simple bar, summaries for groups of cases). Data were presented as three
independent experiments. (Error bars: ± 1 SD). The p-values were assessed using SPSS 21, one-way ANOVA, and
the DUNNETT test. In part B: Col without Mic EpoB and Col with Mic EpoB groups were compared with TCP:
*P < 0.05, **P < 0.01, ***P < 0.001. In part C: The effects of three differentiation groups (TCP, col-without Mic
EpoB, and col-with Mic EpoB) compared with control group (undifferentiated hEnSCs): *P < 0.05, **P < 0.01,
***P < 0.001.
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Figure 9.  Neuronal morphology and neurite outgrowth. (a) Immunofluorescence images indicate neuronal
morphology and neurite elongation of MN-like differentiated hEnSCs after 15 days of induction in collagen
hydrogel with Mic EpoB (2-Col/PA-CH/Mic EpoB) group. (b) Neurite elongation is shown with red arrows. To
display morphology, cells were stained using primary anti-beta III tubulin antibody and secondary Alexa Fluor
488 antibody (× 20 and × 40; Scale bar 100 μm). Neurite length of MN-like cells in 2-Col/PA-CH/Mic EpoB
hydrogel compared to TCP and 2-Col/PA-CH differentiation groups at day 15 after differentiation (***P < 0.001).
PA-CH, respectively (5- and 7-fold change, respectively). The NES and NEFH expressions in the 2-Col/PA-CH/
Mic EpoB hydrogel were almost the same as TCP and 2-Col/PA-CH groups.
Neurite extension. The neurite length of the MN-like cells was significantly longer in 2-Col/PA-CH/Mic EpoB
hydrogels compared to TCP and 2-Col/PA-CH groups (P < 0.001) after 15 days of MN-induction (Fig. 9).

Discussion

In recent years, increasing evidence suggests that small molecules are effective chemical agents for cell survival and differentiation, and may be candidates for various interventional therapies60. Small molecules often
regulate the activity of several transcription factors, which can thereby determine cell fate. Thus, exposing
stem cells to small molecules can advance cell differentiation by mimicking tissue microenvironment during
organogenesis61,62. Ruschel et al. reported low doses of EpoB, known as a small molecule, diminishes fibrotic scar
tissue and induces axonal regeneration in vitro in injured cortical neurons of postnatal r ats37. This study aimed
to evaluate the effect of sustained release of EpoB using PCL microspheres embedded in 3D collagen hydrogel
for differentiation of hEnSCs into MN-like cells.
Many studies have proposed tissue engineering as a practical approach to repairing various damaged tissues,
and nerve tissue engineering is no exception to this rule, especially given the increasing rate of S CI23,63. Many
combinational approaches have proven advantageous compared with using each method separately. However,
these approaches require further elucidation to ensure a meaningful effect compared to their individual u
 sage12.
It is known that ECMs have active roles in cell survival, neuronal differentiation, and neurite development12.
Embedding hydrogels alone without any treatment may slightly improve injury outcomes after S CI8. However,
for the hydrogel approach, it has been shown drug incorporation into hydrogels is necessary for effective healing
of the injured environment8,40.
In this study, we synthesized EpoB/PCL microspheres to have a sustained release during the MN differentiation process. The results indicated that PCL microspheres mediated the sustained release of EpoB as a microtubule-stabilizing small molecule that enhances differentiation of hEnSCs to MN-like cells and increases axonal
elongation. The addition of released EpoB, along with the differentiation protocol, promoted neurite outgrowth
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and neuronal morphology. It also significantly increased the efficiency of motor neuron generation (˃ 96%), and
compared to most recent studies, it gained a higher percentage of motor n
 eurons64,65.
PCL was chosen for microsphere synthesis because of its good biocompatibility, low biodegradation, and
cost-effectiveness39. All four groups of EpoB/PCL microspheres (0, 2.5, 10, and 40 ng/mg) were synthesized using
a single emulsion technique, and their round shape microspheres with a smooth surface were demonstrated by
SEM. Based on the EpoB release test results, the 2.5 ng/mg EpoB/PCL microsphere group was selected for MN
differentiation given a more appropriate dose and drug release and normal size distribution. The indirect MTT
test also confirmed the suitability of 2.5 ng/mg EpoB/PCL microsphere for our purposes with cell viability ˃ 77%
after 72 h.
Recent studies indicate that culturing stem cells in 3D hydrogels improves cell maintenance, expansion, and
differentiation by mimicking the native ECM66,67. For neuronal replacement therapies, given that neurons are
not capable of dividing, stem cell expansion with hydrogel assistance is essential to achieve a suitable cell number
before neuronal differentiation68.
Cell attachment to the ECM is crucial for cell differentiation and proliferation via cell anchoring and activation of signaling pathways that can lead to tissue regeneration and d
 evelopment69–71. Collagen is a key component of the ECM and is extensively used as a scaffold for its effective properties of improving cell attachment,
survival, proliferation, differentiation, and migration72. One study also reported that collagen might promote
higher survival, adhesion, and proliferation of mesenchymal stem c ells73. These cell processes are regulated by
the interaction of collagen with integrins in cell surface r eceptors74. Moreover, collagen has garnered attention
as a delivery system for the sustained release of different drugs and chemical a gents75,76.
GFP cell culture in the two collagen hydrogel concentrations (2 and 4 mg/mL) presented a dose-dependent
proliferation of hEnSC. The lower concentration, 2 mg/mL, was selected because of its greater potential for cell
proliferation and cell connection, which are important for neural differentiation. In line with our study, a previous report indicated that lower concentrations of collagen are more appropriate for neuronal differentiation and
neurite outgrowth77.
Moreover, adding either PA-CH or PA to the collagen hydrogel increased its stability during the 15-day
differentiation process by decreasing the hydrogel’s degradation degree. However, hydrogels cross-linked with
PA-CH showed a greater cell proliferation than PA alone. In addition, cross-linking the collage hydrogel also
decreased the swelling degree of the hydrogel. Interestingly, the 2-Col/PA-CH/Mic EpoB had a slower degradation degree than the collagen and 2-Col/PA-CH groups, which can be attributed to the interactions between
PCL microspheres and the collagen hydrogel. The 2-Col/PA-CH/Mic EpoB had a higher swelling ratio than
the collagen and 2-Col/PA-CH hydrogels. All three groups showed interconnected porous, proper cell-scaffold
integration and cell attachment.
Immunofluorescence staining indicated that the beta III-tubulin marker was increased in all three differentiation groups (i.e., TCP, 2-Col/PA-CH, and 2-Col/PA-CH/Mic EpoB). In agreement with previous reports,
undifferentiated hEnSCs and other sources of human MSCs have a spontaneous expression of this marker78,
demonstrating that it is possible for MSCs such as hEnSCs to undergo neuronal differentiation. Furthermore,
other studies have shown that hEnSCs can induce spinal motor neuron generation during development by upregulating dopamine79. However, compared to the differentiation groups, the undifferentiated hEnSCs in our
study had a lower beta III-tubulin expression. hEnSCs also spontaneously express NES. Thus, both NES and beta
III-tubulin markers show hEnSCs to be a suitable source for neuronal differentiation and spinal cord restoration.
Real-time RT-PCR determined significant gene up-regulation of NEFH, NES, ISL-1, and HB9 after 15 days
of induction. Higher gene expression of ISL-1 and HB9 in the 2-col/PA-CH/MicEpoB group compared to the
other two differentiation groups showed that incorporation of EpoB microspheres in the collagen hydrogels may
significantly increase the MN differentiation efficacy of hEnSCs.
The results show that the release of EpoB from microspheres, in addition to RA and SHH, increase HB9 gene
expression80,81, and can significantly enhance the gene expression of HB9 and also ISL-1, which are two crucial
regulators of mature motor neurons82,83. Moreover, among the other two groups, the 2-Col/PA-CH group demonstrated higher ISL-1 gene expression.
The percentage of HB9 and ISL-1 positive cells is known to be an indicator of motor neuron differentiation
efficiency84. The three differentiation groups, 2-Col/PA-CH/Mic EpoB, 2-Col/PA-CH, and TCP, demonstrated
94%, 84%, and 78% HB9 positive cells, while this was 98%, 88%, and 83% for ISL-1, respectively. This confirms
the higher MN-differentiation efficiency of the 2-Col/PA-CH/Mic EpoB group compared to the other two differentiation groups. This is while a previous study indicated 11.7% and 23.7% positive cells for HB9 and ISL-1,
respectively, for MN-like cells derived from tonsil mesenchymal stem cells (T-MSCs). Also, other studies show
35–46% and 70–90% positive cells for HB9 and ISL-1, respectively, in MN-like cells derived from induced
pluripotent stem cells (iPSCs)85–87.
Furthermore, the neurite length of MN-like cells in the 2-Col/PA-CH/Mic EpoB group increased remarkably
to 146 µm, which is more than three times longer compared to the other two groups without Epo B microspheres
(2-Col/PA-CH, and collagen groups). Recently, it was reported that acellularized spinal cord scaffolds incorporating bpV(pic)/PLGA microspheres promote axonal regeneration by about 45 µm88.
Another study indicated that adding 3 nM of paclitaxel as an MSA can enhance neurite length of mature rat
retinal ganglion cells (RGCs) by 40 µm while using 10 nM paclitaxel significantly decreases neurite outgrowth89.
This shows that paclitaxel has less of an effect on neurite outgrowth than EpoB. Additionally, compared with
paclitaxel, EpoB has a smaller molecular size, higher solubility, and the capability to pass the blood–brain barrier
(BBB)90,91. It is worth noting that EpoB can be effective for axon elongation and MN-differentiation, despite the
presence of the neurite outgrowth inhibitor A, which is known to be an axonal inhibitor in S CI23,26.
One proposed method of increasing neurite outgrowth in recent years is electrical stimulation92–94. A study
reported that the neurite length of PC12 cells via gold-nanoparticle after electrical stimulation (ES) was 120 µm95.
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Another study reported, the final neurite length of the primary prefrontal cortex (PFC) in collagen 3D cultures
with ES to be ~ 110 µm, compared to the control wild-type where only ~ 10 µm of elongation was o
 bserved96.
Thus, our results indicate that the fabricated 2-Col/PA-CH/Mic EpoB hydrogel achieved a higher neurite elongation than the mentioned studies.
While understanding the exact mechanism of EpoB and adapting it to the complex mechanism of SCI yet
need to achieve a clear vision, today its role in stem cell differentiation and SCI has garnered attention, and our
study demonstrated the enhanced MN differentiation efficiency of hEnSCs and neurite growth by 3D crosslinked collagen hydrogel containing EpoB-loaded microspheres which can be used as a combinatorial approach
for MN-diseases modeling and a future aid in SCI repair.

Conclusion

To our knowledge, this is the first time that ultra-low doses of EpoB loaded microspheres have been synthesized for the purpose of MN differentiation from hEnSCs. Our study demonstrates that incorporation of EpoB
microspheres with collagen hydrogel can significantly increase the MN differentiation efficiency of hEnSCs by
up-regulating ISL-1 and HB9, known as mature motor neuron key markers. Moreover, our results showed that
the addition of EpoB microspheres significantly enhances neurite growth during MN differentiation. Utilizing
proanthocyanidin and calcium hydroxide as cross-linkers significantly reduces the degradation degree of the
3D collagen hydrogel and provides an appropriate stable ECM for supporting cell attachment, proliferation,
and differentiation. Our findings emphasize the active role that 3D cross-linked collagen hydrogels containing
EpoB-loaded microspheres for nerve tissue engineering and the potential of using combinatorial approaches to
overcome the limitations of individual methods for SCI repair.

Data availability

The datasets used and/or analyzed during the current study are available on reasonable request.
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